Table 3.
Outcome measure | Three-way interaction |
Moderator effect in total group |
Moderator effect during cancer treatment |
Moderator effect post cancer treatment |
||||
---|---|---|---|---|---|---|---|---|
P* | βinteraction (95%CI) | P* | βinteraction (95%CI) | P* | βinteraction (95%CI) | P* | βinteraction (95%CI) | |
Fatigue | .89 | 0.007 (−0.10 to 0.11) | .05 | −0.05 (−0.10 to 0.000) | – | – | – | – |
Aerobic fitness | .04 | −0.11 (−0.22 to −0.004) | – | – | .002 | 0.11 (0.04 to 0.18) | .95 | 0.002 (−0.08 to 0.08) |
Upper body muscle strength | .10 | −0.10 (−0.21 to 0.02) | – | – | 1.00 | −0.00 (−0.09 to 0.09) | <.001 | −0.11 (−0.17 to −0.05) |
Lower body muscle strength | .05 | −0.12 (−0.24 to 0.002) | – | – | .57 | 0.02 (−0.06 to 0.10) | .01 | −0.10 (−0.18 to −0.02) |
Quality of life | .07 | −0.09 (−0.19 to 0.006) | – | – | .38 | −0.03 (−0.11 to 0.04) | <.001 | −0.13 (−0.19 to −0.06) |
Physical function | .65 | −0.02 (−0.12 to 0.08) | .003 | −0.07 (−0.12 to −0.03) | – | – | – | – |
P values were calculated using a two-sided likelihood ratio test and examining the interaction term of the linear mixed model analyses. Analyses are adjusted for age, sex and cancer type. CI = confidence interval.